Featured

(Editor’s note: This column is part of a recurring series of commentaries from professionals connected to the hemp industry. Andrew M. Rosner and Kaelan Castetter are vice presidents of the New York State Cannabis Growers and Processors Association.) Government officials nationwide are talking about banning the sale of hemp flower in the name of public
Hemp-derived CBD giant Charlotte’s Web Holdings is positioning itself to enter THC and marijuana markets. The Boulder, Colorado, company says it has signed a five-year, $8 million purchase agreement option with a marijuana company started by its founders, Stanley Brothers USA Holdings Inc. The deal allows Charlotte’s Web to take over the marijuana business after
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Jackie Berg is co-founder of CBD Marketing Hub, a digital-to-door agency focused on CBD and cannabis marketing.) Sleep is valued commodity and something many Americans are increasingly bereft of. Many health experts see sleep issues as
The entire cannabis industry is buzzing about delta-8 THC and other cannabinoids found rarely in the plant but gaining favor among growers and consumers. Indeed, there has been a noticeable shift toward so-called novel cannabinoids among hemp producers surveyed by Hemp Industry Daily. But CBD still rules the roost. Cannabidiol, by far, continues to be
Minor cannabinoids have been gathering interest among growers and extractors over the past year, with research on CBG, CBN, CBC and THC-V showing unique health benefits for consumers. But are consumers even aware of these molecules and is there demand in the marketplace? And are there genetics available that can yield enough of these minor
Jillian Hishaw (Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Jillian Hishaw is an agricultural strategist and former U.S. Department of Agriculture Adjudicator of the Office to the Assistant Secretary of Civil Rights. She’s now Founder & CEO of Family Agriculture Resource Management Services
This story first appeared at Marijuana Business Daily. The development of new genetic-editing technology offers cannabis companies a cost-effective way to make specific changes to marijuana and hemp plants – such as more disease resistance – without creating a genetically modified organism. The technology, known as Crispr-Cas9, will allow the cannabis industry to build new,
(This opinion column appears in the February issue of Marijuana Business Magazine.) Everyone in the hemp industry knows the story of Charlotte’s Web: A group of well-meaning brothers working under Colorado’s medical marijuana system developed a cannabis strain that worked miracles on a sick little girl named Charlotte. Word spread about the awe-inspiring results of
(A version of this story appears in the February issue of Marijuana Business Magazine.) From mom-and-pop shops to corporate chains, everyone in the retail business knows that a carefully chosen location is key to success. The cannabis industry is no exception. Although regulatory requirements, license availability and market demand will vary from place to place,
U.S. District Court for the Eastern District of New York Crediting the CBD company’s forthrightness, a federal judge in New York federal judge has dismissed a lawsuit against Massachusetts-based Curaleaf from investors who argued the company misled them about legality of its CBD products. The investors sued when Curaleaf’s share price fell in 2019 after
The National Football League and its players’ union have requested industry research on CBD and other cannabinoids for pain management. The NFL says it is looking for information about “alternatives to opioids in routine pain management.” The request mentions CBD but is open to research on other cannabinoids. The request issued Wednesday also mentions research
A renowned marijuana-growing county in northern California’s Emerald Triangle, Humboldt County, has permanently banned outdoor cultivation of low-THC hemp varieties. The unanimous vote by the county Board of Supervisors last week comes after marijuana interests in the area argued that hemp could send male pollen onto higher-THC varieties and depress cannabinoid levels, the (Eureka) Times-Standard
Hemp genetics companies have been actively pursuing patents to protect their intellectual property after years of work to develop novel genetics. But despite intellectual property protection that became available after the U.S. legalized hemp production in 2018, some companies are still opting for more expensive and more comprehensive plant utility patents for the highest level
3M’s Don Davidson uses everyday sticky notes to demostrate how hemp could become part of tomorrow’s adhesives (photo via National Hemp Symposium) Industrial conglomerate 3M Co. thinks hemp can be part of the sustainability “megatrend” and is looking at hemp components to do everything from strengthening packaging tape to helping grow human tissue and organs.
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Julie Lerner is CEO of PanXchange, a commodity trading platform and benchmark price provider.) Basing the multibillion-dollar, pie-in-the-sky forecasts for the U.S. addressable market for CBD on retail shelf prices disturbs me. It’s as illogical as
In the two years since hemp became a legal commercial crop in the United States, producers’ challenges in sourcing a consistent supply of predictable, reliable genetics haven’t subsided, as the industry establishes itself and plant-breeding efforts continue. Growers looking to source reliable hemp genetics may consider looking at seed from varieties that have been produced
Mexico is moving ahead on medical marijuana regulation — and all hemp and marijuana companies that envision doing business there in the future should start preparing now, lawyers say. The Mexican government has begun setting a regulatory structure for medical cannabis in the country, making it possible for companies to start applying for research licenses
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest
The hemp industry has high hopes for thriving under President Joe Biden, with operators seeing opportunities in the president’s climate plan and feeling optimistic that congressional action on high-THC cannabis will open more opportunities for hemp entrepreneurs. But the industry is still waiting for answers on some of its most pressing concerns, especially the legality